openPR Logo
Press release

Leukocytapheresis Device Market Foraying into Emerging Economies By 2028

09-24-2018 09:39 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

/ PR Agency: Fact.MR
Leukocytapheresis Device Market Foraying into Emerging

Leukocytapheresis, also known as white blood cells removal is therapy to reduce the number of white blood cells in the bloodstream. White Blood Cells (leukocytes) are the part of immune system. They help the body to fight infections. There are three types of leukocytes which are involved in the inflammation of bowels. They are granulocytes, monocytes, and lymphocytes. It was found that inflammatory bowel disease is caused by the release of various cytokines from white blood cells, resulting in inflammation of the bowel. Ulcerative colitis and Crohn’s disease are the most chronic inflammatory bowel diseases. Leukocytapheresis is a method helps at ameliorating symptoms in patients with severe inflammatory bowel disease. In leukocytapheresis therapy, the leukocytes involved in inflammation are removed from the blood using extracorporeal treatment unit. During therapy, blood is pumped from the vein of arm or leg through leukocyte removal filter and leukocyte-reduced blood is returned in the body through opposite vein. Leukocytapheresis aims to reduce the number of leukocytes that are involved in inflammation to dampen the inflammatory reaction. According to the Crohn’s and Colitis Foundation, 1.6 million Americans are affected yearly with inflammatory bowel disease.

Request Sample Report https://www.factmr.com/connectus/sample?flag=S&rep_id=1113

Leukocytapheresis Device Market: Drivers & Restraints

Conventional therapy to treat inflammatory bowel diseases such as pharmacotherapy involves substantial adverse effects and the chance of recurrence is more. Leukocytapheresis therapy overcomes such problem which drives the market of leukocytapheresis devices. Increasing prevalence of inflammatory bowel diseases is the prominent factor responsible for the growth of leukocytapheresis devices market. Leukocytapheresis therapy mainly involves adult patients therefore growing elderly population responsible for the robust the growth of leukocytapheresis devices market. Leukocytapheresis therapy is more expensive than conventional therapy which degrades the leukocytapheresis devices market growth over forecast period. Furthermore, lack of awareness among patients in the under developing economies may deter the growth of leukocytapheresis devices market.

Leukocytapheresis Device Market: Segmentation

The global Leukocytapheresis devices market is segmented on the basis of product type, end user and geography.

Based on product type, leukocytopheresis devices market is segmented into:

Adacolumn
Cellsorba

Based on end user, Leukocytapheresis devices market is segmented into:

Hospitals
Specialty Clinics
Ambulatory Surgical Centers

Leukocytapheresis Device Market: Overview

Excellent clinical efficacy of Cellsorba and Adacolumn increases the growth of leukocytapheresis devices market in Japan and other regions. The effectiveness and safety of leukocytapheresis therapy over conventional therapy increases the leukocytapheresis devices market growth in the overall forecast period. Leukocytapheresis therapy has adverse side effects, simple extracorporeal procedure, requires approximately lesser time compared to conventional therapy. The above all factors increases the wide adoption of leukocytapheresis therapy worldwide and hence increases the overall market growth. Favorable reimbursement policies allows the growth of leukocytapheresis devices market in low economic regions.

Leukocytapheresis Device Market: Regional outlook

Geographically, global leukocytapheresis devices market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding China and Japan, China, Japan, Middle East and Africa. Currently, Japan is the leading market of leukocytapheresis devices because of leading manufacturers in this region. This is followed by North America due to higher adoption among the patients and technological advancement. Moreover, increase in geriatric population also increase the market growth in this region. Europe held the third position in leukocytapheresis devices market due to increase in healthcare expenditure per capita. Asia Pacific region has been expecting the growth in near future due to increase in the patient’s pool. Middle East Asia and Africa show the delayed growth due lack of awareness in these region hinders the growth of leukocytapheresis devices market.

Leukocytapheresis Device Market: Key Players

Some of the key players involve in the leukocytapheresis devices market includes: Asahi Kasei Medical Co., Ltd., JIMRO Co. Ltd. are some of the leading manufacturers of leukocytapheresis devices.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size Analysis
Current Trends/Issues/Challenges
Competition & Companies involved
Value Chain Analysis

The regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
Eastern Europe (Poland, Russia)
Asia-Pacific Excluding China and Japan (India, ASEAN, Australia & New Zealand)
China
Japan
The Middle East and Africa (GCC, S. Africa, N. Africa)

Report Analysis @ https://www.factmr.com/report/1113/leukocytapheresis-device-market

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Leukocytapheresis Device Market Foraying into Emerging Economies By 2028 here

News-ID: 1257283 • Views:

More Releases from Fact.MR

System Integration Market Is Projected To Rise At A CAGR Of 18.7% Through 2034: Fact.MR Report
System Integration Market Is Projected To Rise At A CAGR Of 18.7% Through 2034: …
The global system integration market is estimated to have a valuation of US$ 401.8 billion in 2024. Projections put the CAGR of the market for the 2024 to 2034 period at a remarkable 18.7%. The market's growth over the forecast period is set to inflate significantly, reaching a projected value of US$ 2,236.6 billion by 2034. The System Integration Industry sales study offers a comprehensive analysis on diverse features including production
Bromelain Market Is Forecasted To Reach US$ 56.2 Million By The End Of 2034: Fact.MR Report
Bromelain Market Is Forecasted To Reach US$ 56.2 Million By The End Of 2034: Fac …
Bromelain market size is pegged at US$ 27.3 million for 2024. Worldwide demand for bromelain is predicted to increase at a robust CAGR of 7.5% and reach a market value of US$ 56.2 million by the end of 2034. The Bromelain Industry sales study offers a comprehensive analysis on diverse features including production capacities, Bromelain demand, product developments, sales revenue generation and Bromelain market outlook across the globe. market research report by
Writing Instruments Market Is Projected To Reach US$ 20.54 Billion By The End Of 2034: Fact.MR Report
Writing Instruments Market Is Projected To Reach US$ 20.54 Billion By The End Of …
The global writing instrument market size is calculated at US$ 14.28 billion for 2024 and is projected to reach US$ 20.54 billion by 2034-end. Worldwide demand for writing instruments is projected to expand at a CAGR of 3.7% from 2024 to 2034. The Writing Instrument Industry sales study offers a comprehensive analysis on diverse features including production capacities, Writing Instrument demand, product developments, sales revenue generation and Writing Instrument market outlook
Lifesciences Data Mining and Visualization Market Rising at 9.1% CAGR to Reach US$ 19.9 Billion by 2033
Lifesciences Data Mining and Visualization Market Rising at 9.1% CAGR to Reach U …
The worldwide data mining and visualization market in the life sciences sector is projected to exceed $8.3 billion by 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.1%, reaching $19.9 billion by 2033. In 2022, revenue from data mining and visualization in the life sciences amounted for 7% of the total data analytics market. 𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗮 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆 𝗢𝗳 𝗥𝗲𝗽𝗼𝗿𝘁: https://www.factmr.com/connectus/sample?flag=S&rep_id=459 Using data mining and visualization

All 5 Releases


More Releases for Leukocytapheresis

07-15-2021 | Health & Medicine
Fact.MR
Sales Of Leukocytapheresis Device Market Will Record Exponential Growth During 2 …
The latest study by Fact.MR- (a leading provider of business and competitive intelligence) on the global Leukocytapheresis Devices Market survey offers an overall compilation of the historical, current, and future prospects of the Leukocytapheresis Devices market and the factors responsible for it are such as leukocyte apheresis device market growth The Leukocyte Apheresis Device Market Overview report provides estimates of the size of the Leukocyte apheresis Device Market and the total
Significant Growth Foreseen By Leukocytapheresis Device Market During 2028
A new research report by Fact.MR offers the past, current and Future scenario of Suppliers of Leukocytapheresis Device market across the globe. Key insights pertaining to various application areas of Suppliers of Leukocytapheresis Device has been included in this study that portray an overall standing of the market in terms of revenue generated at a global level. The report also profiles the business and product strategy of some of the
03-12-2021 | Health & Medicine
Fact.MR
Leukocytapheresis Device Market Globally Expected to Drive Growth through 2028 | …
Leukocytapheresis device is used in a nonsurgical treatment to reduce the quantity of white blood cells in the bloodstream. It may be indicated in patients with leukostasis which is resulted from microvascular obstruction by the white blood cells and may lead to hemorrhage in various tissues and organs. Leukocytapheresis device is increasingly adopted in the treatment for leukostasis to quickly reduce the white blood cell count. Additionally, the leukocytapheresis device is
Leukocytapheresis Device Market Expected to Secure Notable Revenue Share during …
Leukocytapheresis device is used in a nonsurgical treatment to reduce the quantity of white blood cells in the bloodstream. It may be indicated in patients with leukostasis which is resulted from microvascular obstruction by the white blood cells and may lead to hemorrhage in various tissues and organs. Leukocytapheresis device is increasingly adopted in the treatment for leukostasis to quickly reduce the white blood cell count. Additionally, the leukocytapheresis device
11-20-2018 | Health & Medicine
Fact.MR
Global Leukocytapheresis Device Market Technological Improvements Steering Growt …
Conventional therapy to treat inflammatory bowel diseases such as pharmacotherapy involves substantial adverse effects and the chance of recurrence is more. Leukocytapheresis therapy overcomes such problem which drives the market of leukocytapheresis devices. Increasing prevalence of inflammatory bowel diseases is the prominent factor responsible for the growth of Leukocytapheresis Device Market. Leukocytapheresis therapy mainly involves adult patients therefore growing elderly population responsible for the robust the growth of leukocytapheresis devices
Leukocytapheresis Device Market Augmented Expansion to be Registered by 2018 to …
Leukocytapheresis, also known as white blood cells removal is therapy to reduce the number of white blood cells in the bloodstream. White Blood Cells (leukocytes) are the part of immune system. They help the body to fight infections. There are three types of leukocytes which are involved in the inflammation of bowels. They are granulocytes, monocytes, and lymphocytes. It was found that inflammatory bowel disease is caused by the release